# A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

> **NCT00693446** · PHASE4 · UNKNOWN · sponsor: **Nantes University Hospital** · enrollment: 118 (estimated)

## Conditions studied

- Pancreas Transplantation
- Kidney Transplantation

## Interventions

- **DRUG:** Sirolimus
- **DRUG:** Tacrolimus

## Key facts

- **NCT ID:** NCT00693446
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-04
- **Primary completion:** 2013-04
- **Final completion:** 2017-04
- **Target enrollment:** 118 (ESTIMATED)
- **Last updated:** 2015-05-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00693446

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00693446, "A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT00693446. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*